Over the past decade CBSET has partnered with more than 400+ MedTech and BioTech companies, including start-ups and industry-leading corporations, enabling them to initiate clinical studies and gain subsequent US and OUS market approvals for their novel therapeutic, imaging and diagnostic technologies.

1. What the Experts at CBSET Are Saying About Local Drug Delivery
New biocompatible materials have enabled improved drug performance through targeted delivery, novel excipients,
and new routes of administration.
PRECLINICAL DRUG STUDIES AT CBSET
Testing Therapeutics and Understanding Complex Pathologies
“CBSET's multi-disciplinary approach can
integrate computational modeling of drug
release, absorption and local tissue distribution.
We pair the complexities of anatomic and
surgical methods with a deep understanding of
drug kinetics to meet a Sponsor’s needs in a
variety of applications, including drug-material
interactions and formulation, controlled-release
therapeutics, and combination drug-device
products.”
Rami Tzafriri, PhD
Director, Research and
Innovation, CBSET Inc.
View Video
Over the past decade CBSET has partnered with more than 400+ MedTech and BioTech companies, including start-ups and industry-leading corporations, enabling
them to initiate clinical studies and gain subsequent US and OUS market approvals for their novel therapeutic, imaging and diagnostic technologies.
CBSET Inc. 500 Shire Way Lexington, MA 02421 USA info@cbset.org 1-781-541-5555